BridgeBio Pharma Inc. BBIO on Wednesday announced a recent presentation of interim results from its Phase 3 FORTIFY trial for BBP-418, a treatment for limb-girdle muscular dystrophy type 2I/R9.

Overall, the research suggests that medications originally developed for diabetes and weight loss may also play a role in protecting the heart. By improving blood flow in the smallest vessels of the ...

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...

Muscle aches are commonly caused by overuse, dehydration, infections, inflammation, or underlying health conditions that affect muscles and the immune system.

The company reported no revenue for the period, and ended 2025 with cash, cash equivalents, and marketable securities of about $318.1 million. ・Capricor is now awaiting the U.S. Food and Drug ...

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or ...

Data presented at the 2026 Muscular Dystrophy Association meeting could have readthroughs to companies developing therapies for spinal muscular atrophy, Duchenne muscular dystrophy and Becker muscular ...

Johnson & Johnson (NYSE:JNJ) today announced results from an open-label, multicenter Phase 1 study evaluating an investigational intravesical drug-releasing system with erdafitinib (Erda-iDRS) in ...

For many men, controlling blood pressure is an important step toward protecting the heart and living a long and healthy life. High blood pressure, also called hypertension, is very common. It often ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

A comprehensive Lancet review synthesizes evidence from major clinical trials showing that GLP-1 receptor agonists and ...

Weight loss drugs such as GLP-1 medications are gaining popularity for their rapid results. These medications, originally designed for diabetes, have been shown to curb appetite and aid weight loss.